期刊文献+

24株洋葱伯克霍尔德菌耐药性分析及β-内酰胺酶耐药基因检测 被引量:11

Drug resistance of Burkholderia cepacia and its resistant genes to β-lactams
下载PDF
导出
摘要 目的了解洋葱伯克霍尔德菌耐药情况及耐药基因,为临床用药提供指导。方法琼脂稀释法检测洋葱伯克霍尔德菌对10种抗生素的最低抑菌浓度(M IC);PCR法测定β-内酰胺酶耐药基因。结果洋葱伯克霍尔德菌对头孢呋辛耐药率最高,达71.5%,其次氨曲南69.9%,左旋氧氟沙星66.7%,美罗培南66.6%,氯霉素62%;耐药率最低的是米诺环素28.6%,其次头孢哌酮/舒巴坦31.6%,头孢吡肟33.3%,哌拉西林/他唑巴坦和头孢他啶分别为36.4%和40.3%。β-内酰胺酶耐药基因IMP-1和VIM-1为阳性,未检出OXA23、OXA10 OXA24、DHA1、VIM-2基因。结论洋葱伯克霍尔德菌对多种抗生素耐药率较高,临床应根据药敏结果合理选药。IMP-1和VIM-1的存在是导致洋葱伯克霍尔德菌对β-内酰胺抗生素耐药的重要机制。 Aim To investigate the change in drug resistance of Burkholderia cepacia strains and its resistant genes to β-lactams for reference of clinical antimicrobial strategy.Methods Minimum inhibitory concentrations(MIC)to 10 kinds of antimicrobial agents were detected by agar dilution method,Then,resistant genes to β-lactams were analyzed by PCR amplification.Results The highest resistant rate of Burkholderia cepacia was in cefuroxime,up to 71.5%,then in aztreonam,levofloxacin,meropenem and chloramphenicol,that is 69.9%,66.7%,66.6%and 62% respectively;the lowest resistant rate was in minocycline,only 28.6%,then in cefoperazone/sulbactam,cefepime piperacillin/tazobactam and ceftazidime which were 31.6%,33.3%,36.4%and 40% respectively.IMP gene 1 and VIM gene 1 of β-lactams were positive.OXA gene 23,OXA gene 10,OXA gene 24,DHA gene 1 and VIM gene 2 were negative.Conclusion Treatment should be guided by drug sensitivity test because the resistant rate of Burkholderia cepacia to many kinds of antimicrobial agents is higher.The existence of IMP gene 1 and VIM gene 1 are the important resistant mechanisms of Burkholderia cepacia to β-lactams antibiotics.
出处 《安徽医药》 CAS 2011年第5期598-599,共2页 Anhui Medical and Pharmaceutical Journal
关键词 洋葱伯克霍尔德菌 最低抑菌浓度 耐药性 耐药基因 Burkholderia cepacia minimum inhibitory concentrations(MIC) drug resistance resistant gene
  • 相关文献

参考文献11

二级参考文献44

共引文献41

同被引文献84

  • 1曹弟勇,周歧新,凌保东.洋葱伯克霍尔德菌及其耐药现状[J].国外医药(抗生素分册),2006,27(6):272-275. 被引量:11
  • 2袁小玲,高绍衍,夏秀琼,黄宇筠,区秀燕,缪炯矞.ICU洋葱伯克霍尔德菌医院下呼吸道感染危险因素及临床分析[J].中华医院感染学杂志,2006,16(12):1356-1358. 被引量:24
  • 3叶应妩,王毓三.全国临床检验操作规程[M].3版.南京:东南大学出版社.2007:472-531.
  • 4.医院感染诊断标准(试行)[S].[S].中华人民共和国卫生部,2001.2..
  • 5桑福德.抗微生物治疗指南[M].第41版.北京:中国协和医科大学出版社,2011:56.
  • 6Clinical and Laboratory Standards Institute. M100-S17 perform-ance standards for antimicrobial susceptibility testing 5 twenty-sec-ond information supplement[S]. Wayne,PA,USA:CLSI,2012.
  • 7叶应妩,王毓三,申子瑜.全国临床检验操作规程[s].3版.南京:东南大学出版社,2007:827-836.
  • 8CLSI. M07/A8-2012. Performance standards for antimicrobial sus- ceptibility testing[ S]. America: Clinical and Laboratory Standards Institute, 2012.
  • 9Sachdev A,Chugh K,SethiM. Diagnosis of ventilatorassociated pneumonia in children in resource-limited setting:A comparative study of bronchoscopic and nonbronchoscopic methods[J].{H}Pediatric Critical Care Medicine,201 ,(02):258-266.
  • 10Clinical and Laboratory Standard Institute.M07-A8 Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically;approved standard-eighth edition[S].2012.

引证文献11

二级引证文献44

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部